Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-10

Clinical Trial Update: Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

View source ↗

Summary

A Brigham and Women's Hospital study is evaluating whether Caveolin-1 deficiency influences response to GLP-1 receptor agonist therapy in individuals with obesi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Overweight and Obesity | Status: RECRUITING